Migraine chronification is associated with a dysfunctional thalamocortical pathway. The present study addressed whether abnormal concentrations of neurochemicals exist in key brain regions of this pathway in chronic migraine. Magnetic resonance spectroscopic imaging of the bilateral medial walls of the brain was used to measure choline, creatine, glutamate and glutamine, myo-inositol, and N-acetyl-aspartate in chronic migraine patients and in matched groups of episodic migraine patients and healthy controls. A region of interest analysis was conducted to examine whether N-acetyl-aspartate, a marker of neuronal integrity, was reduced in the thalamus, occipital cortex and anterior cingulate cortex in chronic migraine. Interregional N-acetyl-aspartate correlations among these regions of interest were also examined. Additionally, statistical mapping was performed for all the metabolites throughout the medial walls. Chronic migraine was associated with N-acetyl-aspartate reductions in the bilateral thalami and in the right anterior cingulate. The N-acetyl-aspartate reduction in the right thalamus correlated with disease duration. Compared with healthy controls, patients with chronic migraine had altered interregional N-acetyl-aspartate correlations between the right thalamus-anterior cingulate and thalamus-occipital cortex, and between the left and right anterior cingulate. N-acetyl-aspartate concentrations and interregional correlations in patients with episodic migraine were between those of healthy controls and chronic migraine patients. The unconstrained analyses revealed a reduction of myo-inositol in the left anterior and posterior cingulate in both patient groups as well as a negative association with depression scores for the anterior cingulate in the combined patient group. In addition, migraine patients with headache on the scan day (irrespective of diagnosis) had reduced N-acetyl-aspartate and total creatine concentrations in the right dorsal anterior cingulate. Reduced N-acetyl-aspartate metabolism and altered interregional N-acetyl-aspartate correlations lend support to the role of thalamocortical dysfunction in migraine chronification. It remains to be established if the pattern of changes within the N-acetyl-aspartate network is specific to chronic migraine or can be found in other chronic pain conditions.
Introduction
Chronic migraine is a complex and disabling brain disorder, with a prevalence of $1.4-2.2% in the general population (Natoli et al., 2010; Stark et al., 2013) . Chronic migraine is defined as 515 headache days per month in the last 3 months and of them, 58 days per month with migraine (Headache Classification Committee of the International Headache Society, 2013). It is not clear why some migraine sufferers progress to the chronic form while others do not. Central sensitization, a state of maladaptive plasticity in the CNS, is thought to have a pivotal role in the transition to chronic pain (Latremoliere and Woolf, 2009) . Patients with chronic migraine often exhibit several of the manifestations associated with central sensitization, including hypersensitivity to non-painful (allodynia) and painful (hyperalgesia) somatosensory input (Bernstein and Burstein, 2012; Harriott and Schwedt, 2014) . Allodynia occurs with greater frequency in long-term migraine sufferers and is considered a risk factor for progression to chronic migraine (Bigal and Lipton, 2006; Bigal et al., 2008; Benatto et al., 2017) . Cephalic and extracephalic allodynia have been linked to sensitization of neurons in the spinal trigeminal nucleus and the posterior thalamus, respectively (Bernstein and Burstein, 2012) . Additionally, altered processing (Burstein et al., 2010) and effective connectivity of the posterior thalamus has been found in migraineurs with allodynia to/from regions subserving affective and cognitive aspects of pain processing (Wang et al., 2016) . Evidence from several other studies also suggests the presence of a dysfunctional thalamocortical pathway in migraine (DaSilva et al., 2007; Coppola et al., 2013 Coppola et al., , 2016a Schwedt et al., 2013; Hodkinson et al., 2016) . Important determinants for the functional changes appear to be the attack frequency and the number of years with migraine. Taken together, thalamocortical dysfunction may in part be responsible for the progression of migraine.
Little is known about the neurochemical changes in the thalamocortical pathway of migraine sufferers and whether such changes are related to the chronification process. Proton magnetic resonance spectroscopy (MRS) offers a unique opportunity to study several brain metabolites simultaneously, e.g. (total) choline (tCho), (total) creatine (tCr), glutamate and glutamine (Glx), myo-inositol, and N-acetyl-aspartate (NAA). These metabolites subserve a diverse range of functions and may reflect cell energy metabolism (tCr), neuronal and axonal integrity (NAA), and excitatory neurotransmission (Glx), among others (Soares and Law, 2009 ). The only two MRS studies in chronic migraine found no changes in the hypothalamus (Wang et al., 2006) or in the brainstem (Lai et al., 2012) . Most MRS studies on episodic migraine have been concerned with the occipital cortex due to the presence of abnormal occipital excitability. Mixed results have been reported for this region including no metabolic changes, reduced NAA/ tCr, increased Glx/tCr, increased lactate, and decreased levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) (Younis et al., 2017) . Decreased NAA/Cr in the thalamus contralateral to the migraine as well as an inverse relationship with attack frequency and disease duration have also been found in episodic migraine (Mohamed et al., 2013) . Finally, two other studies were able to distinguish migraineurs from healthy individuals based on a constellation of metabolites in the anterior cingulate cortex (ACC) (Prescot et al., 2009; Becerra et al., 2016) .
To address whether chronic migraine is associated with abnormal neurochemical changes in the thalamocortical pathway, we used magnetic resonance spectroscopic imaging (MRSI) of the bilateral medial walls of the brain in chronic migraine patients and compared them with matched groups of episodic migraine patients and healthy controls. Initially, a region of interest analysis was performed for NAA concentrations in the left and right thalami, ACC and occipital cortices. These regions have previously been implicated in migraine pathophysiology and in particular, in central sensitization, light hypersensitivity (photophobia) and abnormal excitability (Afridi et al., 2005; Harriott and Schwedt, 2014; Burstein et al., 2015) . Based on the above-mentioned studies, we hypothesized that all regions would exhibit reduced NAA concentrations and that thalamic NAA would be inversely related to attack frequency and/or disease duration. Furthermore, the ACC and the occipital cortex are known to be functionally and anatomically connected to the thalamus (Noseda and Burstein, 2013; Harriott and Schwedt, 2014; Fan et al., 2015; O'Muircheartaigh et al., 2015) . Hence, to further explore the interactions between the regions of interest, an analysis of interregional NAA correlations was performed. Additionally, an anatomically unconstrained voxel-wise analysis was conducted using statistical mapping of tCho, tCr, Glx, myo-inositol, and NAA in the left and right medial walls.
Materials and methods

Study population
Patients with episodic and chronic migraine were recruited from the Headache Clinic of Taipei Veterans General Hospital. The diagnosis of episodic migraine was based on the International Classification of Headache Disorder II (Headache Classification Committee of the International Headache Society, 2004), whereas that of chronic migraine was based on the revised version of the International Classification of Headache Disorders II (Headache Classification Committee of the International Headache Society, 2006). Patients were requested to keep a headache diary and completed a structured questionnaire on demographics, headache profile, past medical history, and usage of medication. To be enrolled in the study, chronic migraine patients were required to fulfil the following criteria: (i) headaches occurring 515 days per month for at least 3 months, with 58 headaches/month fulfilling the criteria of migraine without aura or responding to migraine-specific treatment; (ii) no medication overuse headache, i.e. frequent use of acute abortive medications, as defined by the revised version of the International Classification of Headache Disorders II; and (iii) no previous or current use of prophylactic medication. Patients with episodic migraine were enrolled if they (i) had 1-9 headache days/month, i.e. low-frequency migraine attacks; (ii) were without migraine aura; and (iii) had not previously received prophylactic medications. Healthy controls were recruited from the general population in the Taipei Metropolitan Area via advertisements approved by the Institutional Review Board of Taipei Veterans General Hospital. Healthy controls were recruited if they did not have any history of migraine; however, infrequent tension-type headache (51 headache day/ month) was allowed. Apart from the migraine diagnosis in the patient groups, both patients and healthy controls were normal in physical and neurological examinations and did not have any systemic diseases, psychiatric disorders or conditions incompatible with MRI. Thus, none of the participants received medications on a daily basis. The Institutional Review Board of Taipei Veterans General Hospital approved the study protocol (VGHIRB: 2012-04-046B) and the study was conducted in accordance with the Declaration of Helsinki (sixth revision). All participants provided written informed consent before undergoing any study-related procedures.
Imaging protocol
Images were obtained on a 3 T magnetic resonance scanner (Trio, SIEMENS Medical Solutions) with a 32-channel head coil array. A high-resolution 3D magnetization prepared rapid acquisition gradient echo anatomical scan (repetition time/echo time/flip angle: 2530 ms/3.03 ms/ 7
; field of view: 224 Â 256 Â 192; voxel size: 1 Â 1 Â 1 mm 3 ) was initially acquired for localization of the left and right medial walls for subsequent positioning of MRSI slices. Accelerated MRSI was implemented using a proton echo-planar spectroscopic imaging sequence Tsai et al., 2007 Tsai et al., , 2008 . Two 14-mm thick sagittal MRSI slices covering the medial walls in the left and right hemispheres were acquired separately with an in-plane resolution of 8 Â 8 mm 2 , using the following parameters: repetition time = 1.5 s, echo time = 30 ms, 32 Â 32 spatial matrix, field of view = 256 Â 256 mm 2 , number of excitations per slice = 16. The acquisition order of left and right slices was balanced across participants within each subject group. To reduce the partial volume effect from CSF, the MRSI planes were placed slightly away from the central line. A non-water suppressed MRSI scan was acquired using a single average for automatic phase correction and calibration of metabolite concentrations. For each hemisphere, eight slices of outer-volume lipid suppression were applied along the perimeter of the brain to suppress the lipid signal. Routine shimming and adjustment for water suppression was carried out automatically by the magnetic resonance system. The acquisition time for each water suppressed MRSI scan was 513 min. Following each MRSI scan, multi-slice sagittal T 1 -weighted images were collected using a gradient echo sequence (repetition time/echo time/flip angle: 250 ms/2.61 ms/ 70
; field of view: 256 Â 256; MAT: 256 Â 256; slice thickness: 2 mm). Seven slices were collected in each hemisphere yielding 14-mm volumes covering the same spatial locations as the two MRSI scans. These T 1 images were used as anatomical reference in the following analysis.
Data processing
Standard post-processing and reconstruction strategies for the MRSI data were first implemented Tsai et al., 2007 Tsai et al., , 2008 Niddam et al., 2015) . Spectra were then quantified with the LCModel software package (Provencher, 2001 ) in the range 0.5-4 ppm. Basis sets for spectral fitting included simulated spectra for 15 metabolites, lipids and macromolecules. Metabolic signals were calibrated to the non-water suppressed data using the water scaling method (Gasparovic et al., 2006) and concentrations were initially obtained with a referenced water concentration of 55.55 M (Ernst et al., 1993) . To obtain absolute concentrations, the referenced water concentration used in LCModel was further adjusted for partial volume and tissue relaxation effects according to the voxelspecific concentrations of visible water in grey matter, white matter and CSF (Niddam et al., 2015) . This adjustment also accounted for the metabolite-specific chemical shift displacement. Water concentrations in the three compartments were taken from the literature (Ernst et al., 1993) as were the T 1 and T 2 values used to correct for relaxation effects . Voxels with a CSF tissue probability 40.3 were discarded. Finally, adjusted concentration maps were generated for the following five metabolites: tCho (including glycerophosphocholine and phosphocholine), tCr (including creatine and phosphocreatine), Glx, myo-inositol, and NAA. In addition to the adjusted concentration maps, the metabolitespecific spatial distribution of the Cramer-Rao Lower Bound, as provided by LCModel, was also mapped (not shown). The Cramer-Rao Lower Bound is commonly used to quantify the goodness-of-fit in LCModel (Provencher, 2001) . Concentration values in voxels with unsatisfactory LCModel fits (CramerRao Lower Bound 430%) were discarded. Finally, maps of the line-width (full-width at half-maximum) and the signal-tonoise ratio of the spectra were also generated. These parameters were obtained from LCModel and used as indices of the spectral quality.
Statistical analysis
The left and right hemisphere T 1 images of a representative participant from the control group (female, 35 years of age) was chosen as anatomical frame of references to which left and right individual T 1 images from all participants were warped into (Periaswamy and Farid, 2003) . The corrected metabolite images and spectral quality images were first subsampled to the same resolution as the T 1 images (1 Â 1 mm 2 ) before the individual warp parameters were applied. All images were then imported into the Statistical Parametric Mapping 8 package (Wellcome Trust Center for Neuroimaging, Institute of Neurology, University College London, London, UK) where the images were resliced according to the reference metabolite images. Mean concentration maps, obtained using the ImCalc function, were overlaid on the study-specific anatomical templates in MRIcro (http://cnl.web.arizona.edu/mricro.htm). For display purposes, a cortical mask excluding cerebellar and brainstem regions was applied to the maps.
To test our a priori hypothesis about NAA reductions in chronic migraine patients, a region of interest analysis was performed with regions of interest placed bilaterally in the dorsal/rostral ACC (length, height, width: 20 mm, 25 mm, 14 mm), the thalamus (15 mm, 15 mm, 14 mm) and the occipital cortex (15 mm, 17 mm, 14 mm) (see Supplementary material for the anatomical subregions covered by the regions of interest). Regions of interest were generated with MRIcro and mean NAA concentrations were extracted from each region of interest using an in-house made program running under MATLAB R2012a (The MathWorks Inc, Natick, MA, USA). Additionally, the mean spectral quality parameters (signal-to-noise ratio and full-width at half-maximum) were also extracted from the regions of interest. Between-group comparisons of NAA concentrations within the regions of interest were performed using analysis of covariance with age, gender and depression scores as covariates. This analysis was repeated with the region of interest-specific total grey matter volume (see below) added as a covariate. Hemispheric asymmetry between the corresponding regions of interest was assessed by the laterality index defined as (LeftÀRight)/ (Left + Right). One-sample t-tests were used to test withingroup effects (compared to zero, i.e. no hemispheric asymmetry) and between-group effects were tested using analysis of covariance with the same covariates as above. Pair-wise post hoc analyses among the three groups were performed using Bonferroni tests, which correct for the multiple comparisons.
To further examine interregional NAA correlations in each subject group, Pearson correlation matrices were generated for each group using the NAA concentrations of the six regions of interest. Correlation coefficients were converted into P-values and then corrected for the multiple comparisons (q-values) by controlling for the false discovery rate. Between-group comparisons of the correlation coefficients were performed in a similar way. In all cases, q 5 0.05 was considered significant.
Regional changes in concentrations were examined by a voxel-wise analysis for each of the five metabolites using the Statistical non-Parametric Mapping (SnPM; http://go.warwick. ac.uk/tenichols/snpm) toolbox. The non-parametric approach requires minimal assumptions about the data and has several advantages over the parametric approach when analysing voxel-wise MRSI data (Niddam et al., 2015) . Patient groups were compared with healthy controls using two-sample t-tests. Significance levels were estimated using 20 000 permutations per test. Voxels were evaluated within a cortical mask excluding the cerebellum, the lower brainstem and the ventricles. A voxel-level threshold of 0.01 (T = 2.51), Bonferroni-corrected for the five metabolites tested (0.05/5), was first applied to the concentration maps. Clusters of voxels passing an extent threshold of 0.05 corrected for family-wise errors (FWE) were then deemed significant. Since our approach is novel, an additional explorative analysis was performed using a less conservative extent threshold of 50 voxels. For clusters passing the FWE-corrected extent threshold, correlations between metabolite concentrations and clinical parameters (duration of migraine history, duration of chronic migraine history, headache severity, headache and migraine frequency, and depression scores) were performed within or across patient groups using mean concentrations extracted from regions of interest covering the significant clusters. Of note, scans with no signal in large areas were discarded from the voxel-wise analysis (Supplementary Table 1 ). However, if the affected regions did not overlap with region of interest locations then the data were included in the region of interest analyses.
Between-group comparisons of region of interest spectral quality parameters, total intracranial volume, and demographic and clinical variables were performed using one-way analysis of variance, independent t-tests, chi-square tests, or Fisher's exact test where appropriate. Significant effects from the analysis of variance were followed by post hoc Bonferroni tests, which accounts for the multiple between-group comparisons performed. All of the tests were two-tailed and were considered significant when passing P 5 0.05.
Grey matter structural analysis
To investigate whether changes in grey matter volume contributed to changes in metabolite concentrations, an optimized voxel-based morphometry analysis was performed on the high-resolution anatomical images, following the procedures from our previous studies (Tu et al., 2010; Niddam et al., 2017) (Supplementary material). The analysis proceeded in two steps: a voxel-wise analysis and an analysis of the total grey matter volume, both performed in standard space within the spatially warped regions of interest. In the voxel-wise analysis, grey matter changes within each of the regions of interest were initially assessed by multiple regression across the entire population for which significant between-group differences were found in NAA concentrations. In this analysis, NAA concentration entered as a covariate of interest while adjusting for age, gender, total intracranial volume, and depression scores. To examine group differences in regression slopes, a twosample t-test was set-up with the same covariates, but with an interaction term added for NAA concentrations. The same model, but without NAA concentrations, was used to test for between-group differences in grey matter density within the regions of interest. A liberal uncorrected voxelwise threshold (P = 0.05, extent = 20 voxels) was used for all tests in order not to exclude the possibility of a relationship between grey matter and NAA concentrations. Changes in total grey matter volumes were assessed by first summing over all voxel intensities within each of the regions of interest for each individual, using the spatially warped and smoothed grey matter images. For each region of interest exhibiting significant between-group changes in NAA concentrations, the individual total grey matter volumes and NAA concentrations then entered into a hierarchical multiple regression analysis in which the effects of age, gender, total intracranial volume, and depression scores were controlled for. Finally, the corresponding between-group differences in total grey matter volume within each of the regions of interest were assessed by analysis of covariance, controlling for the effects of the same variables as above.
Results
Demographics and clinical characteristics
A total of 74 individuals completed the study including 25 chronic migraine patients, 24 episodic migraine patients and 25 healthy controls. Demographics and clinical characteristics of the three groups are provided in Table 1 . The three groups did not differ with respect to age, gender, handedness, body height, weight, or smoking and alcohol habits. As expected, the headache and migraine frequencies were significantly higher in the chronic migraine group than in the episodic migraine group but headache severity and history did not differ significantly between the two patient groups. A significantly larger proportion of chronic migraine patients than episodic migraine patients had a headache on the scan day. The headache distribution was mainly bilateral and did not differ between the two patient groups. A significant group effect was found for depression scores. Further post hoc tests showed that depression scores were significantly lower in healthy controls than in any of the two patient groups (healthy controls versus episodic migraine: P = 0.004; controls versus chronic migraine: P = 0.002) but did not differ significantly between episodic migraine and chronic migraine patients. Overall, mean depression scores were within normal range for all three groups. Finally, no difference in total intracranial volume was found between any of the groups. To test the effect of headache status on the scan day irrespective of diagnosis, i.e. episodic migraine or chronic migraine, the patient population was further divided into 21 patients with headache on the scan day and 21 age-and gender-matched patients without headache on the scan day (Supplementary Table 2 ). The two groups differed with respect to scores on the Migraine Disability Assessment Questionnaire (P = 0.025). As expected, the two groups also differed in headache and migraine frequencies (P 5 0.001), as more chronic migraine than episodic migraine patients had headache on the scan day.
Region of interest analysis
For each metabolite, the mean concentration maps exhibited similar metabolite distributions in the two hemispheres and across the three groups. Three types of distributions were found (Fig. 1) . High tCho levels were mainly found in the anterior and thalamic regions, high tCr and NAA levels where mainly found in anterior and posterior/occipital regions, and high Glx and myo-inositol levels were found throughout the medial cortex.
Three key regions of the medial wall of the brain were chosen to examine our hypothesis of reduced NAA concentrations in chronic migraine. Mean NAA concentrations were extracted from bilaterally located regions of interest in the dorsal/rostral ACC, the occipital cortex and the thalamus. In the right hemisphere, a significant effect was found for the ACC (F = 5.08, P = 0.009) and the thalamus (F = 7.39, P = 0.001) but not for the occipital cortex (F = 1.91, P = 0.155). Further post hoc analyses revealed a significant NAA reduction in chronic migraine relative to healthy controls in both the ACC (P = 0.007) ( Fig. 2A) and in the thalamus (P = 0.001) (Fig. 2C) . However, no significant differences were found between episodic migraine and healthy controls (ACC: P = 0.381; thalamus: P = 0.201) or chronic migraine (ACC: P = 0.248; thalamus P = 0.131). It is noteworthy that thalamic NAA concentrations in episodic migraine exhibited a trend towards an increase relative to chronic migraine. In the left hemisphere, a significant effect was found for the thalamus (F = 6.8, P = 0.004) but not for the ACC (F = 1.96, P = 0.151) or the occipital cortex (F = 1.26, P = 0.292). Further post hoc analysis for the left thalamus showed a reduction in NAA concentrations in chronic migraine relative to healthy controls (P = 0.006) and episodic migraine (P = 0.027) (Fig.  2C) but not for episodic migraine relative to healthy controls (P = 1.000). An additional adjustment for the total grey matter volume within the regions of interest increased the P-values slightly but the overall results remained the same (Supplementary material). Furthermore, an effect of headache status on the scan day, irrespective of diagnosis, was not found for any of the regions of interest (Supplementary material). A significant right-hemisphere lateralization was found in the ACC for all three groups (P 5 0.001). Further on, hemispheric lateralization in the thalamus was only found for chronic migraine with the left side higher than the right side (healthy controls: P = 0.581; episodic migraine: P = 0.964; chronic migraine: P 5 0.001). No lateralization was found in the occipital cortex for any of the groups (healthy controls: P = 0.708; episodic migraine: P = 0.212; chronic migraine: P = 0.592). The between-group comparisons revealed no significant effects for any of the regions of interest (ACC: F = 0.864, P = 0.427; thalamus: F = 2.833, P = 0.067; occipital cortex: F = 1.216, P = 0.303), albeit with a borderline significant effect for the thalamic region of interest.
To further investigate the relationship between migraine characteristics and the reduced NAA concentrations in chronic migraine, correlations with clinical parameters were performed within each patient group. A significant negative correlation was found between right thalamic NAA concentrations and disease duration in chronic migraine (n = 22, r = À0.543; P = 0.010). A similar relationship was not found in episodic migraine (n = 22, r = 0.148, P = 0.512) (Fig. 2D ). Significant correlations were neither found for the right ACC nor for the left thalamus in any of the groups.
Explorative analyses within the three regions of interest were performed for tCho, tCr, myo-inositol, and Glx (Supplementary Fig. 1 and Supplementary Table 4). Significant group effects were found for tCr in the left ACC (F = 3.406, P = 0.039) and the left thalamus (F = 5.144; P = 0.008) and for myo-inositol in the right ACC (F = 3.144, P = 0.050). Further post hoc analyses revealed reduced tCr concentrations in chronic migraine relative to healthy controls for both regions of interest (ACC: P = 0.046; thalamus: P = 0.007) but not for episodic migraine relative to healthy controls (ACC: P = 0.125; thalamus: P = 0.459) or chronic migraine relative to episodic migraine (ACC: P = 1.000; thalamus: P = 0.192). The post hoc analyses for myo-inositol showed trends toward significance, albeit without reaching significance (chronic migraine versus healthy controls: P = 0.138; episodic migraine versus healthy controls: P = 0.062). All other comparisons did not result in any significant group effects. 
Interregional NAA correlations
To explore interregional NAA correlations, group-specific correlation matrices, including all the regions of interest, were created. In healthy controls (Fig. 3A and B) , a significant positive correlation was found between the right thalamus and both the right ACC (q = 0.049) and the right occipital cortex (q = 0.003). A positive relationship was also found between left and right ACCs (q = 0.025). It is noteworthy, that trends toward significant positive correlations were found between the thalami of the two hemispheres (q = 0.081), between the left thalamus and the left ACC (q = 0.068), and between the right ACC and the right occipital cortex (q = 0.068). No significant interregional correlations were found in episodic migraine ( Fig. 3C and  D) . However, in chronic migraine patients, the right thalamus correlated positively with the left thalamus (q = 0.032) and negatively with the right ACC (q = 0.032) (Fig. 3E and F) . The Fisher r-to-z transformation was used to pairwise assess between-group differences in the interregional correlation coefficients. These comparisons revealed no significant differences between episodic migraine and healthy controls (Supplementary Fig. 2A ). However, significant differences were found between chronic migraine and healthy controls for thalamic-ACC (q = 0.002) and thalamic-occipital cortex (q = 0.018) correlations in the right hemisphere, and for left and right ACC intercorrelations (q = 0.005) (Supplementary Fig. 2B ). No differences in interregional correlations were found between the two patient groups ( Supplementary Fig. 2C ), indicating that the regression slopes for the episodic migraine group fell inbetween those of the two other subject groups ( Supplementary Fig. 2D ).
Voxel-based morphometry
A voxel-based morphometry analysis within the regions of interest was performed to further investigate whether the were located in (A) the anterior cingulate cortex, (B) the occipital cortex, and (C) the thalamus. NAA concentrations were significantly reduced in chronic migraine (CM) patients relative to healthy controls (HC) in the right anterior cingulate and in the left and right (Rt) thalami (Thal). NAA levels in chronic migraine patients were also significantly reduced relative to patients with episodic migraine (EM) in the left thalamus. (D) A significant negative correlation was found between right thalamus NAA concentrations and migraine history (in years) in chronic migraine (r = À0.543, P = 0.010, n = 22) but not episodic migraine patients (r = À0.148, P = 0.512, n = 22). Error bars indicate standard deviations. *P 5 0.01, **P 5 0.001.
reductions in NAA concentrations in chronic migraine could be related to grey matter changes. In the voxel-wise analysis, a cluster of significantly reduced grey matter density in chronic migraine relative to healthy controls was found only in the right ACC (uncorrected voxel-level P = 0.016; extent = 132 voxels) (Fig. 4A) . In addition, a positive relationship was found between grey matter density and NAA concentrations in the right ACC (uncorrected voxel-level P = 0.019; extent = 242 voxels) (Fig. 4B) . No significant differences were observed in regression slopes between the two groups or in the analysis of total grey matter volume within each region of interest. 
Spectral quality
Between-group differences in spectral quality, as indexed by the line-width (full-width at half-maximum) and signal-tonoise ratio, within the regions of interest were only found for the left ACC (full-width at half-maximum: F = 7.23, P = 0.001) and the right occipital cortex (signal-to-noise ratio: F = 7.03, P = 0.002) (Supplementary Table 3 ). Post hoc analyses showed a significantly increased linewidth in chronic migraine relative to both healthy controls and episodic migraine (P = 0.004 and P = 0.007, respectively) for the left ACC and an increased signal-to-noise ratio in chronic migraine relative to healthy controls (P = 0.001) for the right occipital cortex. Thus, a systematic difference in spectral quality was not found.
Voxel-wise analysis
For each of the five metabolites, an unconstrained voxelwise analysis was performed to further explore regional changes (Fig. 5) . A conservative statistical criterion was implemented for which we first applied a voxel-level threshold corrected for the five metabolites tested (P = 0.01). Clusters of voxels passing an FWE corrected extent threshold (P FWE = 0.05) were then considered significant. For both episodic and chronic migraine, reduced myo-inositol concentrations were found in the left posterior cingulate (episodic migraine: extent = 142, P FWE = 0.041; chronic migraine: extent = 377, P FWE = 0.002). Additional reductions in myo-inositol concentrations were found for chronic migraine in the left mid-cingulate (extent = 201, P FWE = 0.015) and the left ACC (extent = 320, P FWE = 0.004). Using a less conservative extent threshold (extent 4 50 voxels) to further explore the data, reduced myo-inositol concentrations were alsvo found in the left ACC for episodic migraine (extent = 71, P FWE = 0.1573). The explorative analysis further revealed increased tCho concentrations in the left dorsal thalamus (extent = 70, Figure 5 Cluster-level analysis for metabolites in the left medial wall using statistical nonparametric mapping. Left and right columns correspond to comparisons of episodic (EM) and chronic (CM) migraine patients with healthy controls (HC). A voxelwise threshold corrected for the five metabolites tested (P 5 0.01, T = 2.51) was initially applied. Clusters passing an FWE-corrected extent threshold were deemed significant. An additional explorative analysis was performed for clusters larger than 50 voxels. Dark blue clusters: decreased concentrations in the patient group and an extent passing FWE-correction. Light blue clusters: decreased concentrations in the patient group and an extent passing 50 voxels. Pink clusters: increased concentrations in the patient group and an extent passing 50 voxels. mI = myo-inositol. Figure 4 Grey matter density and the relation to NAA levels in the right ACC. Left: Compared to healthy controls (HC), patients with chronic migraine (CM) exhibited a decrease in grey matter density (yellow) within the region of interest located in the right anterior cingulate (red). Right: Grey matter exhibiting a positive association with NAA within the same region of interest across both healthy controls and patients with chronic migraine. A liberal uncorrected voxel-wise threshold (P = 0.05, extent = 20 voxels) was used for all tests. Results are shown in standard space and are overlaid on a template from the Statistical Parametrical Mapping 8 package. Also, regions of interest, in our study-specific template space, were warped into standard space.
P FWE = 0.1699) for chronic migraine, but not for episodic migraine. Further on, decreases in tCr concentrations were found in the left occipital cortex for both episodic migraine (extent = 58, P FWE = 0.2075) and chronic migraine (extent = 71, P FWE = 0.1712) and in the left medial prefrontal cortex for episodic migraine (extent = 50, P FWE = 0.2695). Finally, decreased NAA concentrations were found in the left ACC (extent = 71, P FWE = 0.1795) and the left occipital cortex (extent = 78, P FWE = 0.1545) in chronic migraine. No clusters in the right medial wall passed our statistical criteria. To test for associations with clinical parameters, correlation analyses were performed with mean concentrations extracted from regions of interest encompassing the significant clusters. For myo-inositol concentrations in the left hemisphere, clusters overlapped in location between the two patient groups in the anterior and posterior cingulate. A significant negative correlation was found with depression scores across all patients in the ACC (n = 47, r = À0.322, P = 0.026) and a trend towards a negative correlation was found with depression scores in the posterior cingulate (n = 47, r = À0.259, P = 0.075) (Fig. 6) . No other associations were found with clinical parameters and metabolite concentrations. Finally, the effect of headache status on the scan day, irrespective of headache diagnosis, was examined for all five metabolites in each hemisphere using two-sample t-tests with scores on the Migraine Disability Assessment Questionnaire, and either headache or migraine frequency as covariates. Significant clusters of reduced NAA (P FWE = 0.002, k = 300) and tCr (P FWE = 0.015, k = 266) were found in the right dorsal ACC when using headache frequency, but not migraine frequency, as a covariate (Supplementary Fig.  3 ). However, lowering the voxel-wise statistical threshold to 0.05 in the latter analysis resulted in clusters for both metabolites overlapping with those from the headache frequency analysis (results not shown).
Discussion
The present study addressed whether abnormal concentrations of neurochemicals exist in key brain regions of the thalamocortical pathway in chronic migraine. Based on a region of interest analysis, we first showed that chronic migraine is associated with reduced bilateral thalamic NAA and that the NAA reduction in the right thalamus correlated with the disease duration. Additionally, an NAA reduction was found in the right ACC in chronic migraine. We further showed altered interregional NAA correlations in chronic migraine compared with healthy controls for right thalamic-ACC and thalamic-occipital cortex intercorrelations, and for left and right ACC intercorrelations. Finally, the unconstrained voxel-wise analyses revealed a reduction in myo-inositol concentrations in the anterior and posterior cingulate in both patient groups as well as a negative association with depression scores in the ACC for the combined patient group. In addition, migraine patients with headache on the scan day had reduced NAA and tCr concentrations in the right dorsal ACC.
Reduced NAA concentrations
Reduced NAA concentrations in the thalamus and the ACC have not previously been reported in chronic migraine. As in our study, others found no NAA change in the ACC in episodic migraine (Prescot et al., 2009; Gonzalez de la Aleja et al., 2013; Becerra et al., 2016) . Furthermore, in our study thalamic NAA concentrations in episodic migraine only exhibited a trend towards a reduction relative to healthy controls and an increase relative to chronic migraine. However, decreased thalamic NAA levels have previously been reported in episodic migraine (Mohamed et al., 2013) . This discrepancy may be due to various methodological differences, including demographics, scan Figure 6 Correlation between myo-inositol concentrations and depression scores. Decreases in left myo-inositol (mI) concentrations in the two patient groups overlapped in the anterior (red) and the posterior (blue) cingulate. A negative correlation between mean myo-inositol concentrations and depression scores (Beck Depression Inventory, BDI) were found for both regions across all patients. However, the relationship was only significant for the anterior cingulate (anterior cingulate: r = À0.322, P = 0.026, n = 47; posterior cingulate: r = À0.259, P = 0.075, n = 47).
parameters and region of interest size. The more pronounced NAA reduction in the right than left thalamus in chronic migraine resulted in a significant leftward hemispheric shift. This was not the case in the ACC for which a rightward shift was found in all subject-groups. Hemispheric lateralization in the ACC has previously been observed functionally and structurally and may be related to processes involved in physiological arousal, attention reorientation and pain (Symonds et al., 2006; Corbetta et al., 2008; Yan et al., 2009; Wang et al., 2013) .
Both the thalamus and ACC are engaged during spontaneous migraine attacks (Afridi et al., 2005) and exhibit atypical functional connectivity in chronic migraine (Schwedt et al., 2013) . The thalamus is, however, not only involved in pain processing per se, but is also part of the substrate responsible for the sensory hypersensitivity in auditory, visual and somatosensory systems often observed in migraine patients (Harriott and Schwedt, 2014) . The thalamus may, therefore, have a particularly important role in migraine chronification. The ACC has been implicated in different aspects of pain perception, including descending modulation and pain affect, and possibly also contributes to the chronic pain state (de Tommaso et al., 2005; Bliss et al., 2016) . Changes in the thalamus and ACC, as well as in other brain regions, may not be specific to migraine as a wide range of pain conditions exhibit similar alterations (Burstein et al., 2015; Ito et al., 2017) . In this respect, other pain conditions associated with central sensitization also exhibit reduced thalamic NAA levels (Fukui et al., 2006; Gustin et al., 2014) .
NAA is mainly synthesized in neurons and NAA changes have been linked to neuronal viability, density and function (Rae, 2014; Landim et al., 2016) . A reduction in NAA concentrations, as observed in our study, could result from various factors, including decreased synthesis, increased catabolism, neuronal loss, and decreased mitochondrial density. Congruent with our findings, grey matter atrophy has previously been reported in the ACC, but not in the thalamus, in migraine (Kim et al., 2008; Valfre et al., 2008; Hougaard et al., 2016) . The synthesis and catabolism of NAA is, among others, regulated by dopaminergic and glutamatergic receptor activation, respectively (Rae, 2014) . Since trigeminothalamic neurons in the sensory thalamus receive dopaminergic input from the hypothalamus and glutamatergic input from the trigeminal nucleus caudalis (Burstein et al., 2015) , migrainerelated processes have the potential to directly regulate thalamic NAA levels. Thus, the reduced thalamic NAA levels could result from altered feedback modulation and/ or repetitive neurovascular input. NAA concentrations in the right thalamus also exhibited a negative relationship with disease duration in chronic migraine. Since episodic and chronic migraine did not differ with respect to this parameter, additional undetermined factors have to be included to explain this relationship. For example, it is conceivable that the thalamus in patients progressing to the chronic state is particularly susceptible or vulnerable to long-term pain.
The reduced NAA concentrations in the right ACC in chronic migraine may represent neuronal damage related to the ongoing headache. This is not only congruent with our finding of reduced grey matter density in chronic migraine compared with healthy controls but also with the positive association between NAA levels and grey matter density within parts of the right ACC region of interest. Further support for this notion comes from our voxelwise finding of reduced NAA and tCr in the right dorsal ACC in patients with headache on the scan day. This region overlapped with the superior portion of the ACC region of interest. The reduced tCr further suggests the energy metabolism to be affected in this region. It is noteworthy that although the analysis of headache status was adjusted for headache or migraine frequencies, we cannot entirely rule out a bias as more chronic migraine than episodic migraine patients were in the headache group. Further investigation is warranted to clarify if these differences remain when headache and non-headache groups are balanced with respect to their diagnosis.
Interregional NAA correlations
A distinct pattern of interregional NAA correlations was observed in chronic migraine in which reduced intercorrelations were found between the right thalamus and both the right ACC and occipital cortex as well as between the left and right ACC. Little is known about NAA brain networks and how they relate to structural and functional brain networks as measured with other imaging modalities. A straightforward relationship between grey matter changes and NAA concentrations has not been found, despite NAA being considered as a neuronal marker (Rae, 2014 ). However, network-level interactions may also occur through modulation of NAA metabolism by specific neurotransmitters, as discussed above, or through the direct coupling of NAA synthesis to glucose metabolism, an indicator of brain activity (Baslow, 2003; Rae, 2014) . The thalamus is structurally and functionally connected with the ACC and the occipital cortex (Noseda and Burstein, 2013; Harriott and Schwedt, 2014; Fan et al., 2015; O'Muircheartaigh et al., 2015) and altered functional connectivity involving these regions have been found in migraine (Schwedt et al., 2013; Wang et al., 2016) . The observed changes in interregional NAA correlations might serve as a compensatory mechanism in response to, on the one hand, excessive sensory and altered modulatory inputs to the thalamus, and on the other hand, neuronal damage in the right ACC. The latter may be driven by ongoing right-lateralized ACC activation during pain (Symonds et al., 2006) . The shift in interregional correlations between the thalamus and the ACC from positive in healthy controls to negative in chronic migraine further supports the notion of substantial neuronal reorganization in pain pathways in chronic migraine.
Myo-inositol and depression scores
A reduction in myo-inositol concentrations was found in the anterior and posterior cingulate in both episodic and chronic migraine. Additionally, a negative association with depression scores was found in the ACC for the combined patient group. This is congruent with the significantly elevated depression scores in both. A negative relationship between depression scores and myo-inositol levels in the ACC has previously been found in patients with major depressive disorder, schizophrenia and to some extent, bipolar disorder (Silverstone et al., 2005; Chen et al., 2014; Chiappelli et al., 2015) . The direction of the relationship between myo-inositol levels and depression scores may be regional specific, as increased myo-inositol levels have been reported for the dorsolateral prefrontal cortex in migraine patients with major depression (Lirng et al., 2015) . The underlying mechanisms for the association of myo-inositol with depression scores remain unclear. The functional roles of myo-inositol include involvement in the phosphoinositol signalling pathway, an intracellular second messenger system, as well as in osmoregulation, i.e. cell volume regulation (Rae, 2014) . A reduction in myo-inositol levels may be interpreted as glial dysfunction as myo-inositol is mainly found in glial cells (Rae, 2014) .
Methodological considerations
In the present study, we used short echo time accelerated MRSI of the bilateral medial walls of the brain to measure absolute concentrations of tCho, tCr, Glx, myo-inositol, and NAA. We have previously shown that these metabolites can be robustly estimated and reproduced with this imaging method, albeit with the best results obtained for tCr, tCho and NAA and for larger regions of interest (Tsai et al., 2012) . The increase in reproducibility with larger region of interest volume is primarily due to a better signal-to-noise ratio but other factors, such as reduced sensitivity to head movement, also contribute. However, an inherent limitation of larger regions of interest is the reduced anatomical specificity. Hence, medium-sized volumes were chosen in the region of interest analysis of our study to balance these factors.
For healthy controls, the mean spectral quality within the regions of interest were similar or better than those from a previous study of ours (Tsai et al., 2012) . This can be explained by differences in region of interest sizes and locations as well as the increased number of excitations (16 versus 8) used in the present study. More importantly, the reduced NAA concentrations in chronic migraine cannot be explained by the observed variation in spectral quality across subject groups. Although spectral quality did not differ significantly between subject groups for the thalamic regions of interest, the signal-to-noise ratio tended to be larger for chronic migraine than healthy controls. However, increases in the signal-to-noise ratio are typically associated with increases in metabolite concentrations and not reductions as observed in our study. In addition, such a trend was not observed for the right ACC in which NAA reductions were also found.
A hypothesis-free unconstrained voxel-wise analysis was performed in addition to the hypothesis-driven region of interest analysis. To improve the reliability of this approach, a conservative cluster-based analysis was performed in which the thresholds were corrected for the number of metabolites as well as for the spatial extent of the clusters. A cluster-level threshold was chosen to avoid spurious noise, particularly along the edge of cortex. However, the combined criteria may have proven too strict, especially for anatomical regions restricted in size, such as the thalamus. In fact, subthreshold clusters in the voxel-wise analysis were found for NAA in the thalamus. This can in part explain why the findings from the region of interest analysis were not mirrored in the voxel-wise analysis for NAA. Another contributing factor may be the improved signal-to-noise ratio obtained by integrating over multiple voxels (Tsai et al., 2012; Larsen et al., 2016) .
It is noteworthy that due to the relatively large thalamic region of interest size in our study, it is not possible to discern the contribution of specific thalamic subregions to the NAA reductions and the altered interregional NAA correlations. Nonetheless, our region of interest covered the regions in the posterior thalamus receiving trigeminovascular input as well as the regions exhibiting connectivity with the occipital cortex and the ACC (Supplementary material).
In conclusion, chronic migraine, but not episodic migraine, is associated with reduced NAA metabolism in the thalamus and the ACC as well as with altered interregional NAA correlations between the thalamus and both the ACC and the occipital cortex. These results lend support to the role of a dysfunctional thalamocortical pathway in migraine chronification. Although NAA reductions in the thalamus and the ACC may not be specific to migraine, it remains to be established whether the observed pattern of changes within the NAA network are specific to chronic migraine or can be found in other chronic pain conditions. 
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